• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

关于人抗纤溶酶与低分子量形式纤溶酶之间反应的动力学

On the kinetics of the reaction between human antiplasmin and a low-molecular-weight form of plasmin.

作者信息

Wiman B, Boman L, Collen D

出版信息

Eur J Biochem. 1978 Jun 1;87(1):143-6. doi: 10.1111/j.1432-1033.1978.tb12360.x.

DOI:10.1111/j.1432-1033.1978.tb12360.x
PMID:149657
Abstract

The reaction between antiplasmin (A) and a low-molecular-weight form of plasmin (P) proceeds in at least two steps: a fast reversible second-order reaction followed by a slower irreversible first-order transition, and may be represented by: P +A k1 in equilibrium k-1 PA k2 leads to PA'. The low-Mr plasmin, which is obtained by limited elastase digestion, is composed of an intact B chain and a small A chain lacking the lysine-binding sites. The k1 of the reaction is (6.5 +/- 0.5) x 10(5) M-1 s-1 which is 30--60 times smaller than that for normal plasmin and antiplasmin. The dissociation constant of the first step is 1.9 x 10(-9) M which is 10 times higher than for normal plasmin and antiplasmin. The rate constant of the second step is (4.2 +/- 0.2) x 10(-3) s-1 for both normal and low-Mr plasmin. Low Mr plasmin which has substrate bound to its active site does not react or reacts only very slowly with antiplasmin. The reaction rate, however, is only slightly influenced by 6-aminohexanoic acid in concentrations up to 1 mM which decrease the reaction rate of normal plasmin approximately 50-fold. The findings further indicate that the lysine-binding site(s) of plasmin are of great importance for the rate of its reaction with antiplasmin.

摘要

抗纤溶酶(A)与低分子量形式的纤溶酶(P)之间的反应至少分两步进行:先是快速可逆的二级反应,接着是较慢的不可逆一级转变,其反应过程可用下式表示:P + A ⇌ k1 k - 1 PA → k2 PA'。通过有限的弹性蛋白酶消化获得的低分子量纤溶酶,由完整的B链和缺少赖氨酸结合位点的小A链组成。该反应的k1为(6.5 ± 0.5)×10⁵ M⁻¹ s⁻¹,比正常纤溶酶和抗纤溶酶的k1小30 - 60倍。第一步的解离常数为1.9×10⁻⁹ M,比正常纤溶酶和抗纤溶酶的解离常数高10倍。第二步的速率常数,正常纤溶酶和低分子量纤溶酶均为(4.2 ± 0.2)×10⁻³ s⁻¹。活性位点结合有底物的低分子量纤溶酶不与抗纤溶酶反应或反应非常缓慢。然而,浓度高达1 mM的6 - 氨基己酸对反应速率的影响很小,而同样浓度的6 - 氨基己酸可使正常纤溶酶的反应速率降低约50倍。这些发现进一步表明,纤溶酶的赖氨酸结合位点对其与抗纤溶酶的反应速率至关重要。

相似文献

1
On the kinetics of the reaction between human antiplasmin and a low-molecular-weight form of plasmin.关于人抗纤溶酶与低分子量形式纤溶酶之间反应的动力学
Eur J Biochem. 1978 Jun 1;87(1):143-6. doi: 10.1111/j.1432-1033.1978.tb12360.x.
2
On the specific interaction between the lysine-binding sites in plasmin and complementary sites in alpha2-antiplasmin and in fibrinogen.关于纤溶酶中赖氨酸结合位点与α2-抗纤溶酶及纤维蛋白原中互补位点之间的特异性相互作用。
Biochim Biophys Acta. 1979 Jul 25;579(1):142-54. doi: 10.1016/0005-2795(79)90094-1.
3
Kinetics of the reactions between streptokinase, plasmin and alpha 2-antiplasmin.链激酶、纤溶酶与α2-抗纤溶酶之间反应的动力学
Eur J Biochem. 1979 Oct;100(1):125-32. doi: 10.1111/j.1432-1033.1979.tb02040.x.
4
Reaction of human alpha2-antiplasmin and plasmin stopped-flow fluorescence kinetics.人α2-抗纤溶酶与纤溶酶反应的停流荧光动力学
FEBS Lett. 1996 May 27;387(1):58-62. doi: 10.1016/0014-5793(96)00429-2.
5
Stopped-flow fluorescence kinetics of bovine alpha 2-antiplasmin inhibition of bovine midiplasmin.牛α2-抗纤溶酶抑制牛中纤溶酶的停流荧光动力学
Biochem J. 1995 Jan 1;305 ( Pt 1)(Pt 1):97-102. doi: 10.1042/bj3050097.
6
Serpin-serine protease binding kinetics: alpha 2-antiplasmin as a model inhibitor.丝氨酸蛋白酶抑制剂-丝氨酸蛋白酶结合动力学:以α2-抗纤溶酶作为模型抑制剂
Biochemistry. 1991 Jan 29;30(4):979-86. doi: 10.1021/bi00218a014.
7
Purification and reaction mechanisms of the primary inhibitor of plasmin from human plasma.人血浆纤溶酶原激活物抑制物-1的纯化及反应机制
Biochem J. 1978 Nov 1;175(2):635-41. doi: 10.1042/bj1750635.
8
[Features of the interaction between alpha2-antiplasmin and plasminogen/plasmin].[α2-抗纤溶酶与纤溶酶原/纤溶酶之间的相互作用特征]
Ukr Biokhim Zh (1999). 2002 Nov-Dec;74(6):83-90.
9
Soluble fibrin preparations inhibit the reaction of plasmin with alpha 2-macroglobulin. Comparison with alpha 2-antiplasmin and leupeptin.可溶性纤维蛋白制剂可抑制纤溶酶与α2-巨球蛋白的反应。与α2-抗纤溶酶和亮抑酶肽的比较。
Biochem J. 1991 Apr 1;275 ( Pt 1)(Pt 1):53-9. doi: 10.1042/bj2750053.
10
Analysis of plasmin binding and urokinase activation of plasminogen bound to the Heymann nephritis autoantigen, gp330.纤溶酶与海曼肾炎自身抗原gp330结合以及纤溶酶原的尿激酶激活分析。
Arch Biochem Biophys. 1992 Dec;299(2):255-60. doi: 10.1016/0003-9861(92)90272-x.

引用本文的文献

1
Plasmin Inhibitor in Health and Diabetes: Role of the Protein as a Therapeutic Target.健康与糖尿病中的纤溶酶抑制剂:该蛋白作为治疗靶点的作用
TH Open. 2022 Nov 18;6(4):e396-e407. doi: 10.1055/a-1957-6817. eCollection 2022 Oct.
2
Redistribution of TPA Fluxes in the Presence of PAI-1 Regulates Spatial Thrombolysis.PAI-1 存在时 TPA 通量的再分配调节空间溶栓。
Biophys J. 2020 Aug 4;119(3):638-651. doi: 10.1016/j.bpj.2020.06.020. Epub 2020 Jun 26.
3
Fibrinolytic Enzymes for Thrombolytic Therapy.纤维蛋白溶解酶用于溶栓治疗。
Adv Exp Med Biol. 2019;1148:345-381. doi: 10.1007/978-981-13-7709-9_15.
4
Site-specific PEGylation of micro-plasmin for improved thrombolytic therapy through engineering enhanced resistance against serpin mediated inhibition.通过工程改造增强对丝氨酸蛋白酶抑制剂介导抑制的抗性,实现微纤溶酶的位点特异性聚乙二醇化,以改善溶栓治疗。
PLoS One. 2019 May 29;14(5):e0217234. doi: 10.1371/journal.pone.0217234. eCollection 2019.
5
Criteria for the Specific Measurement of Plasmin Inhibitor Activity Using an Enzymatic Procedure.使用酶促方法特异性测量纤溶酶抑制剂活性的标准。
EJIFCC. 2001 Jul 22;13(2):61-66. eCollection 2001 Jul.
6
Co-ordinated spatial propagation of blood plasma clotting and fibrinolytic fronts.血浆凝血和纤维蛋白溶解前沿的协调空间传播。
PLoS One. 2017 Jul 7;12(7):e0180668. doi: 10.1371/journal.pone.0180668. eCollection 2017.
7
Biophysical Mechanisms Mediating Fibrin Fiber Lysis.介导纤维蛋白纤维溶解的生物物理机制。
Biomed Res Int. 2017;2017:2748340. doi: 10.1155/2017/2748340. Epub 2017 May 28.
8
Purification and characterization of mutant miniPlasmin for thrombolytic therapy.突变型 miniPlasmin 的纯化与表征及其在溶栓治疗中的应用。
Thromb J. 2013 Jan 30;11(1):2. doi: 10.1186/1477-9560-11-2.
9
The plasmin-antiplasmin system: structural and functional aspects.纤溶酶-抗纤溶酶系统:结构与功能方面。
Cell Mol Life Sci. 2011 Mar;68(5):785-801. doi: 10.1007/s00018-010-0566-5. Epub 2010 Dec 7.
10
The human alpha(2)-plasmin inhibitor: functional characterization of the unique plasmin(ogen)-binding region.人α(2)-纤溶酶抑制剂:独特的纤溶酶(原)结合区域的功能特征。
Cell Mol Life Sci. 2010 May;67(9):1505-18. doi: 10.1007/s00018-010-0264-3. Epub 2010 Jan 29.